Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling

Area of Science:

• Biomedical Research
• Pathology
• Drug Discovery

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, necessitates effective disease models.
• Traditional animal and monolayer models inadequately represent human tissue responses to SARS-CoV-2.
• There is a critical need for advanced models for COVID-19 research and therapeutic development.

Purpose of the Study:

• To review the application of induced pluripotent stem cell (iPSC)-derived 3D organoid models for COVID-19 research.
• To evaluate the potential of various organoids in modeling SARS-CoV-2 infection and its pathological effects.
• To assess the utility of organoids in drug screening for COVID-19 treatments.

Main Methods:

• Comprehensive literature review of studies utilizing iPSC-derived organoids for COVID-19 modeling.
• Analysis of different organoid types, including lung, brain, cardiac, intestinal, liver, kidney, blood vessel, and inner ear organoids.
• Evaluation of organoids' capacity to recapitulate human tissue responses to SARS-CoV-2.

Main Results:

• iPSC-derived organoids, including lung, brain, and cardiac models, show significant promise in mimicking COVID-19 pathology.
• These 3D models offer a more physiologically relevant platform than traditional models for studying viral infection.
• Organoids facilitate the investigation of multi-organ effects and the screening of potential drug therapies with reduced toxicity.

Conclusions:

• iPSC-derived organoids represent a state-of-the-art approach for COVID-19 modeling and drug discovery.
• Organoid technology provides a powerful tool for understanding SARS-CoV-2 pathogenesis and developing effective treatments.
• The use of diverse organoid systems is crucial for comprehensive COVID-19 research.